Literature DB >> 3289800

The immune response to the cell wall of Mycobacterium bovis BCG.

I M Orme1.   

Abstract

Mice were immunized with the cell wall of BCG suspended in an oil-in-saline emulsion, and examined against time for the emergence of T cell-mediated acquired immunity. Evidence is presented that shows that levels of acquired resistance expressed in these animals over the first month following inoculation, and which enabled them to substantially resist an intravenous challenge infection with Mycobacterium tuberculosis, were completely nonspecific in nature, in that they were equally well expressed in normal and T cell-deficient mice, and were present at a time when no protective T cell activity could be passively transferred from the inoculated host. Paradoxically, in contrast, weak but statistically significant protective immunity could be detected in the spleens of CW-immunized mice approximately 3 months after inoculation, at a time when the donor animals were devoid of resistance to rechallenge. Finally, evidence is presented that shows that the CW material, if given subcutaneously, is highly immunogenic for the generation of delayed-type hypersensitivity effector T cells; however, these cells do not themselves contribute to protective immunity.

Entities:  

Mesh:

Year:  1988        PMID: 3289800      PMCID: PMC1541686     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis.

Authors:  I M Orme
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

2.  Dissociation between delayed-type hypersensitivity and resistance to pathogenic mycobacteria demonstrated by T-cell clones.

Authors:  S Hussein; J Curtis; H Akuffo; J L Turk
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

3.  Biologically active components from mycobacterial cell walls. V. Granuloma formation in mouse lungs and guinea pig skin.

Authors:  T J Meyer; E Ribi; I Azuma
Journal:  Cell Immunol       Date:  1975-03       Impact factor: 4.868

4.  A monoclonal antibody discriminating between subsets of T and B cells.

Authors:  J Bruce; F W Symington; T J McKearn; J Sprent
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

5.  A simple method for counting adherent cells: application to cultured human monocytes, macrophages and multinucleated giant cells.

Authors:  A Nakagawara; C F Nathan
Journal:  J Immunol Methods       Date:  1983-01-28       Impact factor: 2.303

6.  Duration of immunity to tuberculosis in mice vaccinated intravenously with oil-treated cell walls of Mycobacterium bovis strain BCG.

Authors:  R L Anacker; W R Barclay; W Brehmer; C L Larson; E Ribi
Journal:  J Immunol       Date:  1967-06       Impact factor: 5.422

7.  Effective nonliving vaccine against experimental tuberculosis in mice.

Authors:  E Ribi; C Larson; W Wicht; R List; G Goode
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

8.  Macrophage Migration Inhibition Studies with Cells from Mice Vaccinated with Cell Walls of Mycobacterium bovis BCG: Relationship Between Inhibitory Activity of Lung Cells and Resistance to Airborne Challenge with Mycobacterium tuberculosis H37Rv.

Authors:  K Yamamoto; R L Anacker; E Ribi
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

9.  Effectiveness of cell walls of Mycobacterium bovis strain BCG administered by various routes and in different adjuvants in protecting mice against airborne infection with Mycobacterium tuberculosis strain H37Rv.

Authors:  R L Anacker; W R Barclay; W Brehmer; G Goode; R H List; E Ribi; D F Tarmina
Journal:  Am Rev Respir Dis       Date:  1969-02

10.  Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients.

Authors:  I M Orme; F M Collins
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

View more
  9 in total

1.  An essential role for endogenous interferon-gamma in the generation of protective T cells against Mycobacterium bovis BCG in mice.

Authors:  J Yang; M Mitsuyama
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

2.  Differences in components at delayed-type hypersensitivity reaction sites in mice immunized with either a protective or a nonprotective immunogen of Cryptococcus neoformans.

Authors:  Kasie L Nichols; Sean K Bauman; Fredda B Schafer; Juneann W Murphy
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

3.  Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice.

Authors:  K Huygen; D Abramowicz; P Vandenbussche; F Jacobs; J De Bruyn; A Kentos; A Drowart; J P Van Vooren; M Goldman
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

4.  Requirement of the initial production of gamma interferon in the generation of protective immunity of mice against Listeria monocytogenes.

Authors:  J Yang; I Kawamura; M Mitsuyama
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

5.  Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis-infected mice with a disruption in the intracellular adhesion molecule 1 gene.

Authors:  C M Johnson; A M Cooper; A A Frank; I M Orme
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

6.  In vitro T-cell profile induced by BCG Moreau in healthy Brazilian volunteers.

Authors:  C Ponte; L Peres; S Marinho; J Lima; M Siqueira; T Pedro; P De Luca; C Cascabulho; L R Castello-Branco; P R Z Antas
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines.

Authors:  I M Orme
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

8.  Adjuvant treatment increases the resistance to Mycobacterium avium infection of mycobacteria-susceptible BALB/c mice.

Authors:  A P Castro; A P Aguas; M T Silva
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

9.  The role of host soluble inflammatory mediators induced by the BCG vaccine for the initiation of in vitro monocyte apoptosis in healthy Brazilian volunteers.

Authors:  Jessica Lima; Mariana Siqueira; Paulo R Z Antas; Thaíze Pedro; Carlos Ponte; Leandro Peres; Suelen Marinho; Luíz R Castello-Branco
Journal:  J Inflamm (Lond)       Date:  2015-10-29       Impact factor: 4.981

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.